Most of the Intended Management Changes After (68)Ga-DOTATATE PET/CT Are Implemented

In this prospective referring-physician–based survey, we investigated the definite clinical impact of (68)Ga-DOTATATE PET/CT on managing patients with neuroendocrine tumors (NETs). Methods: We prospectively studied 130 patients with (68)Ga-DOTATATE PET/CT referred for initial or subsequent managemen...

詳細記述

保存先:
書誌詳細
出版年:J Nucl Med
主要な著者: Calais, Jeremie, Czernin, Johannes, Eiber, Matthias, Fendler, Wolfgang P., Gartmann, Jeannine, Heaney, Anthony P., Hendifar, Andrew E., Pisegna, Joseph R., Hecht, J. Randolph, Wolin, Edward M., Slavik, Roger, Gupta, Pawan, Quon, Andrew, Schiepers, Christiaan, Allen-Auerbach, Martin S., Herrmann, Ken
フォーマット: Artigo
言語:Inglês
出版事項: Society of Nuclear Medicine 2017
主題:
Theranostics
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5666645/
https://ncbi.nlm.nih.gov/pubmed/28473600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.192450
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料